Study directory

ADHD studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1740studies shown
Showing 565-576 of 1,740
Drug study icon
CompletedNCT00485628

Safety Study in Outpatient Japanese Children With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Tokyo
Why is this study shown?

This study is directly about ADHD.

ADHDDrugA study involving a medication or substance.From 6 Years to 17 Years
Countries
Japan
Sponsor
Eli Lilly and Company
Condition
ADHD
Drug study icon
CompletedNCT00640185

Safety study of ABT-089 in ADHD

This study is completed in the United States. It is testing ABT-089 for ADHD.

Multiple locations, including Lafayette
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
AbbVie (prior sponsor, Abbott)
Condition
ADHD
Drug study icon
TerminatedNCT02163915

Safety study of Multiple Rising Doses of TAK-137 in ADHD

This study was terminated in the United States. It is testing Multiple Rising Doses of TAK-137 for ADHD.

In Marlton
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Takeda
Condition
ADHD
Drug study icon
CompletedNCT00586157

Medication Patch to Treat Children Ages 6-12 With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Cambridge
Why is this study shown?

This study is directly about ADHD.

ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.